FisherVista

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) announces new retail media agreements with brands including Under Armour, Santa Barbara Polo Club, Slazenger, Rollox and SwissBrand to advertise on its smart cart platform in Israel, advancing monetization of its in-store media network.

Forward Industries invests in OnRe and plans to deploy up to $25 million into its tokenized reinsurance platform, expanding its treasury strategy into tokenized real-world assets.

McEwen Inc. will host its Q1 2026 conference call on May 7 to discuss financial results and project developments, highlighting its gold, silver, and copper assets.

SKYX Platforms Corp. will install its plug-and-play smart technologies in The Grand Hotel du Parc in France, cutting renovation time and cost by up to 90% and opening opportunities for recurring revenue.

OptimumBank Holdings announces leadership transition with Chairman Moishe Gubin appointed as CEO and Braden R. Smith as President, effective May 1, 2026, as Timothy Terry retires.

SPARC AI Inc. has hired Senergy Communications Capital Inc. for marketing and investor awareness, with a focus on its GPS-denied navigation technology for drones.

AI Maverick Intel Inc. announced commercial progress at HEAL Access Canada Inc., including over 10 live implementations and 13 enterprise agreements, ahead of its proposed acquisition.

ESGold Corp. acquires 44 mineral claims totaling 2,448 hectares in Quebec's Montauban region, strengthening its position around the Montauban Gold-Silver Project.

Search Minerals Inc. granted 1.8 million stock options to incentivize its team as it advances critical rare earth elements projects in Labrador.

G Mining Ventures Corp. announced its Oko West Gold Project in Guyana is 19.7% complete with $292 million spent, on schedule and budget for first gold pour in H2 2027 and commercial production by January 2028.

Oragenics Inc. advances its Phase IIa clinical trial for ONP-002, a potential first-in-class concussion treatment, with active enrollment at a second site and four patients dosed, aiming for a data readout by year-end 2026.

Creatd, Inc. has completed its 2025 audit, reported 113% revenue growth, and filed an amended S-1 with the SEC, positioning itself for a national exchange uplisting and strategic AI-driven acquisitions.

Nightfood Holdings Inc. is leveraging AI-powered robotics and hotel acquisitions to capitalize on accelerating global demand for service robotics, as highlighted in an AINewsWire editorial.

McEwen Inc. filed an independent NI 43-101 technical report for its Tartan Mine Project in Manitoba, supporting a mineral resource estimate of 308,900 ounces of gold in indicated and 302,700 ounces in inferred resources, highlighting the company's growing gold and silver production base.

Premier Graphene, Inc. has delivered a portion of its first military contract from Mexico's SEDENA, positioning the company for follow-on supply agreements in graphene-enhanced defense products across Latin America.

First Orion and Vodafone are partnering to bring network-based branded calling to enterprise customers in the UK, helping businesses improve answer rates by displaying verified caller identities amid rising scam call concerns.

SS Innovations International announced that over 10,500 surgeries have been performed with its SSi Mantra surgical robotic system, highlighting its rapid adoption and potential to democratize robotic surgery worldwide.

AtlasClear Holdings will present at the Emerging Growth Conference on May 7, 2026, to discuss its progress in scaling its correspondent clearing platform and its strategy to build a technology-enabled financial infrastructure platform.

As communities impose moratoriums on large AI datacenters due to power, water, and land constraints, Auddia highlights LT350’s distributed, grid-supportive architecture as a scalable solution.

Aclarion announces a second commercial agreement with Weill Cornell Medicine to use its Nociscan platform in a trial led by Dr. Roger Härtl, aiming to better understand degenerative disc disease and improve treatment outcomes.